ARCA biopharma, Inc. (Nasdaq: ABIO) announced the pricing of the previously announced public offering of the Company’s preferred stock. ARCA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE